Ole Nielsen

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 7 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: H. Lundbeck A/s, Cephalon, Inc., House of Prince A/s. Active years: 1996-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ole Nielsen. Retrieved from https://idiyas.com/inventor/ole-nielsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 57.1

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 42(Granted Patents)

Location History:

DK-8600 Silkeborg, DK (1996 - 1998)
Silkeborg, DK (2013)
Valby, DK (2005 - 2014)
Aalborg, DK (2019)

Company Filing History:

Intelligent Systems A/s

patent

5. 3 out of 834,659

Other

patents

Years Active: 1996-2019

Loading Chart...

Areas of Expertise:

Pharmaceutical Compounds

Crystalline Forms

Orodispersible Tablets

Hydrogen Succinate Salts

Treatment Systems

Data Communication

Valves Control

Citalopram Preparation

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10219964 - Transport and storage system for servicing of a number of treatment and care areas in a hospital and method for operation hereof (2019-03-05),

2. 8729065 - Crystalline forms of a pharmaceutical compound (2014-05-20),

3. 8397947 - Apparatus and a method and a system for dispensing goods (2013-03-19),

4. 8227607 - Processes for 4-((1R,35)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof (2012-07-24),

5. 8076342 - Malonate salt of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same (2011-12-13),

6. 8076320 - Crystalline forms of a pharmaceutical compound (2011-12-13),

7. 7834201 - Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base (2010-11-16),

8. 7767683 - Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament (2010-08-03),

9. 7723533 - Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base (2010-05-25),

10. 7560576 - Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base (2009-07-14),

11. 7112686 - Process for the preparation of racemic citalopram and/or S-or R-citalopram by separation of a mixture of R-and S-citalopram (2006-09-26),

12. 6844352 - 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4′-piperidine] hydrohalogenides (2005-01-18),

13. 5704586 - Apparatus for controlling a valve (1998-01-06),

14. 5589813 - Data communication system of the field bus type with a twin lead for (1996-12-31),

Title: Ole Nielsen: Innovator in Hospital Transport Systems and Pharmaceutical Compounds

Introduction

Ole Nielsen is a distinguished inventor based in Valby, Denmark, known for his significant contributions to the fields of hospital transport systems and pharmaceutical compounds. With a total of 14 patents to his name, Nielsen has demonstrated a commitment to innovation that addresses critical needs in healthcare.

Latest Patents

Nielsen's latest patents include a transport and storage system designed for servicing multiple treatment and care areas within a hospital. This innovative system features a first transport route dedicated to clean goods and a second route for non-clean goods, ensuring efficient and hygienic operations. The design incorporates a partition with a lock gate, enhancing the separation of goods during transport. Additionally, he has developed crystalline forms of a complex pharmaceutical compound, along with methods for their preparation and use, showcasing his versatility as an inventor.

Career Highlights

Throughout his career, Ole Nielsen has worked with notable companies, including H. Lundbeck A/S, where he has contributed to advancements in pharmaceutical technology. His work has had a lasting impact on the efficiency of hospital operations and the development of new medicinal compounds.

Collaborations

Nielsen has collaborated with talented individuals such as Heidi Lopez De Diego and Michael Harold Rock, further enriching his innovative endeavors.

Conclusion

Ole Nielsen's contributions to the fields of hospital transport systems and pharmaceutical compounds highlight his role as a leading inventor. His work continues to influence healthcare practices and pharmaceutical advancements, making a significant difference in the industry.

Profile summary based on public USPTO records.